Clexane and Vancomycin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clexane (enoxaparin sodium) and Vancomycin (vancomycin). Common drug interactions include erythema among females and toxic epidermal necrolysis among males.
The phase IV clinical study analyzes what interactions people have when they take Clexane and Vancomycin. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.
What is Clexane?
Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.
What is Vancomycin?
Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.
43 people who take Clexane and Vancomycin together, and have interactions are studied.

What are the common drug interactions of Clexane and Vancomycin, by gender? *:
female:
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Neuropathy peripheral (surface nerve damage)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Disease progression
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Back pain
- Chest pain
- Confusional state
male:
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Drug hypersensitivity
- Faeces discoloured
- Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
- Hepatic failure (liver failure)
- Malaise (a feeling of general discomfort or uneasiness)
- Nephropathy toxic (damage to kidney due to toxins)
- Pyrexia (fever)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Skeletal injury (bone and supporting muscle injury)
What are the common drug interactions of Clexane and Vancomycin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Disease progression
- Back pain
- Chest pain
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- Excessive eye blinking (excessive blinking is dry eyes)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Lower respiratory tract infection
- Mucosal inflammation (infection of mucous membrane)
- Nausea (feeling of having an urge to vomit)
40-49:
- Device related infection
- Skeletal injury (bone and supporting muscle injury)
50-59:
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Drug hypersensitivity
- Endocarditis (inflammation in heart muscle)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bile duct stone
- Cholecystitis acute (rapid infection of gallbladder)
- Duodenal perforation (complication of duodenal ulcer)
- Faeces discoloured
- Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
- Malaise (a feeling of general discomfort or uneasiness)
60+:
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Death
- Hepatic failure (liver failure)
- Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
- Pneumomediastinum (air is present in the mediastinum)
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Skin cancer
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Neuropathy peripheral (surface nerve damage)
What are the existing conditions these people have? *
- Ill-Defined Disorder: 22 people, 51.16%
- Pneumonia: 21 people, 48.84%
- Erythema Multiforme (a type of hypersensitivity reaction): 18 people, 41.86%
- Diabetes: 13 people, 30.23%
- Fever: 6 people, 13.95%
- Pain: 5 people, 11.63%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 11.63%
- Nausea (feeling of having an urge to vomit): 4 people, 9.30%
- High Blood Pressure: 4 people, 9.30%
- Constipation: 4 people, 9.30%
* Approximation only. Some reports may have incomplete information.
Do you take Clexane and Vancomycin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Clexane (14,679 reports)
- Vancomycin (17,165 reports)
Browse all drug interactions of Clexane and Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clexane:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clexane and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vancomycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on enoxaparin sodium and vancomycin (the active ingredients of Clexane and Vancomycin, respectively), and Clexane and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Retin-A and Prolia - 6 seconds ago
- Drug interactions of Xylocaine and Lexapro - 11 seconds ago
- Levothyroxine Sodium and Vitamins drug interactions for women aged 30-39 - 12 seconds ago
- Could Latanoprost cause Haemorrhage? - 27 seconds ago
- Could Epipen cause Faeces Discolored? - 28 seconds ago
- Montelukast Sodium and Stomachache for Women aged 50-59 - 35 seconds ago
- Montelukast Sodium and Stomach Pain for Women aged 50-59 - 35 seconds ago
- Montelukast Sodium and Pain - Abdomen for Women aged 50-59 - 35 seconds ago
- Montelukast Sodium and Belly Ache for Women aged 50-59 - 36 seconds ago
- Montelukast Sodium and Abdominal Cramps for Women aged 50-59 - 36 seconds ago